https://www.selleckchem.com/products/cu-cpt22.html
This study is conducted to investigate efficacy of pomegranate juice on inflammatory biomarkers, C-reactive protein (CRP), interleukin 6(IL-6), erythrocyte sedimentation rate (ESR) and complete blood count (CBC) in hospitalized patients with mild to moderate coronavirus disease 2019 (COVID- 19). This is a randomized, placebo-controlled, double-blind, parallel 2-arm (11 ratio) clinical trial. Patients with COVID-19 admitted to hospitals in Yasuj City, Kohgiluyeh and Boyer-Ahmad Province, Iran. Informed consent Patients 18 years of age o
Like
Comment
Share
